Treventis Corp.

Treventis Corp.

TREVENTIS ™ Corporation is a biotechnology company focused on therapeutics and diagnostics for protein misfolding diseases. Our lead therapeutics program aims to halt the progression of Alzheimer’s Disease with a single anti-misfolding small molecule targeting the earliest misfolding events of both beta-amyloid and tau, the hallmarks of Alzheimer's pathology.  TREVENTIS' proprietary platform for the design of small molecule anti-misfolding agents enables drug discovery for unique programs in Alzheimer's, Parkinson's, ALS, and other neurodegenerative diseases of protein misfolding.
 

Area of focus: 
Diagnostics, Neuroscience
Commencement date: 
02/01/2017

Share